Autos
In a note on Friday, Zacks Investment Research increased their rating of SORL Auto Parts, Inc. (NASDAQ:$SORL) from ‘Sell’ to ‘Hold’. On Friday, SORL opened at $3.97. The company has a market cap of $76.64 ... [Read]
Articles by Dylan Bernhardt
Healthcare
Investors are currently taking a closer look at Organovo Holdings, Inc (NASDAQ:$ONVO), noting encouraging results thus far. The stock currently moved 1.48% up, to a trading price of $2.06. The stock also had 0.69 million ... [Read]
Basic Materials
Investors at Trevali Mining Corp (TSXV:$TV) can expect an EPS of $0.02 per share according to a Tuesday report from Cormark’s equities research analysts. Analyst S. Ioannou stated that the $0.02 forecast was an increase ... [Read]
Computer Hardware
In a report issued Friday, the analysts at ValuEngine have dropped the SunPower Corporation (NASDAQ:$SPWR) rating from ‘Hold’ to ‘Sell’. SunPower is an energy company that operates globally. They focus on selling solar solutions to ... [Read]
Semiconductors
In a note on Friday, Zacks Investment Research lowered the Camtek Ltd. (NASDAQ:$CAMT) rating from ‘Buy’ to ‘Hold’. During Friday trading, Camtek traded up 1.04% for a total of $4.86. They have a market capitalization ... [Read]
Computer Hardware
According to analysts, now is the ideal time to buy stocks of Axcelis Technologies, Inc. (NASDAQ:$ACLS). During trading on Tuesday, stock prices surged up 1.43% to $24.90. The company also experienced massive trade volume, with ... [Read]
Biotechnology
Iovance Biotherapeutics, Inc (NASDAQ:$IOVA) has announced pricing for their $50 million common stock offering. The company will offer 7,692,308 shares of its common stock at the price of $6.50 per share. Gross profits from this ... [Read]
Application Software
Russell Investments Group Ltd has purchased 8,500 stocks of Imperva Inc (NYSE:$IMPV). This increases Russell’s stake by 1,235.5% in the second quarter. They now own 9,188 and are worth roughly $440,000 as of the purchases ... [Read]
Biotechnology
In a report published on Tuesday morning, Zacks Investment Research has upgraded its rating of VBI Vaccines, Inc (NASDAQ:$VBIV) from a ‘Sell’ rating to a ‘Hold’. VBIV is a biotechnology company that is focused on ... [Read]
Consulting and Outsourcing
Rent-A-Center, Inc. (NASDAQ:$RCII) has recently faced scrutiny from savvy analysts who see dwindling revenues as a sign of a downturn. Despite this, however, the company has responded with a three-pillar strategy back in April that ... [Read]